Syngene International LtdHealthcare Research- Analytics and TechnologyINE398R01022Consolidated₹369.05-11.15 (-2.93%)Jun-26
Valuation
Market Cap₹14.90K Cr
TTM PE67.10x
Forward PE72.27x
PEG-2.22
Book Value₹119.88
P/B3.08x
TTM EPS₹5.50
Fwd EPS₹5.11
TTM Revenue₹3.60K Cr
TTM PAT₹221.00 Cr
TTM EBITDA₹802.90 Cr
TTM EBIT₹349.00 Cr
Last Qtr PAT₹-9.00 Cr
Last Qtr EBITDA₹90.80 Cr
Last Qtr EBIT₹-21.40 Cr
Profitability
ROE4.57%
ROCE6.37%
TTM NPM6.14%
TTM EBITDA %22.30%
Curr OPM-1.18%
Last OPM13.97%
Curr NPM—
Last NPM—
Curr EPS₹-0.22
Last EPS₹3.68
Balance sheet
Equity₹402.90 Cr
Reserve₹4.44K Cr
Total Debt₹458.40 Cr
D/E0.09x
Interest %-106.67%
Curr Interest₹9.60 Cr
Price / range
Close₹369.05
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D-2.93%
1W-3.55%
1M-8.67%
3M-16.18%
6M-12.03%
1Y-43.94%
2Y-58.65%
3Y-53.95%
5Y-42.95%
Diwali-43.19%
Sector peers — Healthcare Research- Analytics and Technology
| Company | Close | Mkt Cap | TTM P/E | ROE |
|---|
| SYNGENE | 369.05 | ₹14.90K Cr | 67.10 | 4.57% |
| INDGN | 600.10 | ₹14.46K Cr | 35.91 | 12.77% |
| SUVEN | 341.55 | ₹9.65K Cr | -22.94 | -59.59% |
| VIMTALABS | 603.10 | ₹2.69K Cr | 22.62 | 13.43% |
| BI | 109.14 | ₹256.97 Cr | -22.32 | — |
| TAKE | 15.96 | ₹236.10 Cr | 40.92 | 41.35% |
| JSTL | 81.25 | ₹161.84 Cr | -49.85 | — |
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits